We are live on
!
Find out more
BFM
Boston Financial Management Portfolio holdings
AUM
$3.31B
1-Year Est. Return
19.4%
This Fund
S&P 500
This Quarter
Est. Return
+1.08%
1 Year Est. Return
+19.4%
3 Year Est. Return
+30.07%
5 Year Est. Return
+107.8%
10 Year Est. Return
+274.5%
AUM
$648M
AUM Growth
–
Cap. Flow
+$656M
Cap. Flow
% of AUM
101.29%
Top 10 Holdings %
Top 10 Hldgs %
30.29%
Holding
199
New
199
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$67M |
| 2 |
ExxonMobil
XOM
|
+$23M |
| 3 |
IBM
IBM
|
+$21.7M |
| 4 |
Johnson & Johnson
JNJ
|
+$15.5M |
| 5 |
Procter & Gamble
PG
|
+$14M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.15% |
| 2 | Consumer Staples | 11.73% |
| 3 | Energy | 11.08% |
| 4 | Technology | 10.95% |
| 5 | Industrials | 10.36% |
Similar funds
CANY
MWM
CCM
ECG
LSAG
KL
WP
RDIA
Boston Financial Management's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Boston Financial Management, which disclosed 199 positions worth $648M. Its ten largest holdings account for 30% of the portfolio.
Its largest position is Pfizer: 2,424,540 shares worth $64.4M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, followed by Consumer Staples and Energy.
- Boston Financial Management's largest Q2 2013 buy was Pfizer: 2,424,540 shares worth $64.4M.
- Boston Financial Management's ten largest holdings make up 30% of its $648M portfolio in Q2 2013.
- Boston Financial Management disclosed 199 positions in Q2 2013, its first 13F filing on record.
Based on Boston Financial Management's 13F filing for Q2 2013, filed 19 Aug 2013.